3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
8
Lung Neoplasms
5
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Hot Flashes
2
Glioblastoma
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Water-Electrolyte Imbalance
1
Ventilator-Induced Lung Injury
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Severe Acute Respiratory Syndrome
1
Rectal Neoplasms
1
Postoperative Complications
1
Pathologic Complete Response
1
Neoplasm, Residual
1
Mastocytosis
1
Lymphopenia
1
Lymphoma, Non-Hodgkin
1
Lymphedema
1
Lower Urinary Tract Symptoms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Hypersensitivity
1
Interventions
Temozolomide
69
Bevacizumab
40
Radiotherapy
22
Magnetic Resonance Spectroscopy
20
Irinotecan
17
Specimen Handling
10
Carboplatin
10
Carmustine
9
X-Rays
7
Radiation
7
olaparib
6
Surgical Procedures, Operative
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Nivolumab
6
Everolimus
6
Cyclophosphamide
6
Biopsy
6
trametinib
5
Thalidomide
5
Cisplatin
5
pembrolizumab
4
palbociclib
4
fluorodopa F 18
4
erdafitinib
4
dabrafenib
4
Lomustine
4
Etoposide
4
Drug Therapy
4
Doxorubicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Glioma
×
Sodium Chloride
×
Clear all
NCT02465268
2025-01-14
ATTAC-II
University of Florida
Phase 2
Completed
175 enrolled
18 charts